FERGIcor, a Randomized Controlled Trial on Ferric Carboxymaltose for Iron Deficiency Anemia in Inflammatory Bowel Disease
Top Cited Papers
- 1 September 2011
- journal article
- research article
- Published by Elsevier in Gastroenterology
- Vol. 141 (3), 846-853.e2
- https://doi.org/10.1053/j.gastro.2011.06.005
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- The efficacy and safety of current intravenous iron preparations for the management of iron-deficiency anaemia: a reviewArzneimittelforschung, 2010
- Ferric Carboxymaltose in Patients with Heart Failure and Iron DeficiencyNew England Journal of Medicine, 2009
- Common Misconceptions in the Diagnosis and Management of Anemia in Inflammatory Bowel DiseaseAmerican Journal of Gastroenterology, 2008
- Systematic review: managing anaemia in Crohn's diseaseAlimentary Pharmacology & Therapeutics, 2006
- Effects of changes in hemoglobin level on quality of life and cognitive function in inflammatory bowel disease patientsInflammatory Bowel Diseases, 2006
- Anemia of Chronic DiseaseNew England Journal of Medicine, 2005
- Iron, anaemia, and inflammatory bowel diseasesGut, 2004
- Tissue iron deficiency without anemia impairs adaptation in endurance capacity after aerobic training in previously untrained womenThe American Journal of Clinical Nutrition, 2004
- Iron supplementation for unexplained fatigue in non-anaemic women: double blind randomised placebo controlled trialBMJ, 2003
- Randomised study of cognitive effects of iron supplementation in non-anaemic iron-deficient adolescent girlsThe Lancet, 1996